2017年12月29日星期五

Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration

Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration

K Sakamoto, Y Adachi, Y Komoike, Y Kamada… - Biochemical and …, 2017 - Elsevier
Abstract Dedicator of cytokinesis 2 (DOCK2) is a key molecule for lymphocyte activation and
migration. DOCK2 interacts with Ras-related C3 botulinus toxin substrate 1 (Rac1, GTPase)
and mediates the GDP-GTP exchange reaction, indicating that inhibitors against protein-



For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论